Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NERO: a biomedical named-entity (recognition) ontology with a large, annotated corpus reveals meaningful associations through text embedding.
Wang K, Stevens R, Alachram H, Li Y, Soldatova L, King R, Ananiadou S, Schoene AM, Li M, Christopoulou F, Ambite JL, Matthew J, Garg S, Hermjakob U, Marcu D, Sheng E, Beißbarth T, Wingender E, Galstyan A, Gao X, Chambers B, Pan W, Khomtchouk BB, Evans JA, Rzhetsky A. Wang K, et al. Among authors: chambers b. NPJ Syst Biol Appl. 2021 Oct 20;7(1):38. doi: 10.1038/s41540-021-00200-x. NPJ Syst Biol Appl. 2021. PMID: 34671039 Free PMC article.
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19.
Strunz B, Maucourant C, Mehta A, Wan H, Du L, Sun D, Chen P, Nordlander A, Gao Y, Cornillet M, Bister J, Kvedaraite E, Christ W, Klingström J, Geanon D, Parke Å, Ekwall-Larson A, Rivino L, MacAry PA, Aleman S, Buggert M, Ljunggren HG, Pan-Hammarström Q, Lund-Johansen F, Strålin K, Björkström NK; Karolinska KI/K COVID-19 Study Group. Strunz B, et al. J Infect Dis. 2024 Feb 29:jiae036. doi: 10.1093/infdis/jiae036. Online ahead of print. J Infect Dis. 2024. PMID: 38421006
Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Gonzalez JS, Bebu I, Krause-Steinrauf H, Hoogendoorn CJ, Crespo-Ramos G, Presley C, Naik AD, Kuo S, Johnson ML, Wexler D, Crandall JP, Bantle AE, Arends V, Cherrington AL; GRADE Research Group. Gonzalez JS, et al. Diabetes Care. 2024 Apr 1;47(4):610-619. doi: 10.2337/dc23-2459. Diabetes Care. 2024. PMID: 38416773
Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study).
Green JB, Everett BM, Ghosh A, Younes N, Krause-Steinrauf H, Barzilay J, Desouza C, Inzucchi SE, Pokharel Y, Schade D, Scrymgeour A, Tan MH, Utzschneider KM, Mudaliar S; GRADE Study Research Group. Green JB, et al. Circulation. 2024 Mar 26;149(13):993-1003. doi: 10.1161/CIRCULATIONAHA.123.066604. Epub 2024 Feb 12. Circulation. 2024. PMID: 38344820 Clinical Trial.
398 results